Prediction of the Immune Escape Potential and Immunotherapy Response of PCC Patients.
(A) Circle plots depicting inferred inter-cellular interactions in metabolism-type (left) and kinase-type (right) PCC microenvironment. (B) Box plots showing the expression levels of HLA-A, HLA-B, and HLA-C in metabolism-type and kinase-type PCC patients. (C) Immunohistochemistry staining of CGA and HLA-A in formalin-fixed paraffin-embedded PCC tissue sections matched to scRNA-seq specimens. Scale bar, 100 μm. (D) UMAP plot showing 8 immune cell types detected from all PCC specimens. (E) Dot plot of representative marker genes for each immune cell type. The color scale represents the average marker gene expression level; dot size represents the percentage of cells expressing a given marker gene. (F) Comparison of the proportion of immune cell types in tumor vs adjacent normal adrenal medullary tissues. (G) Multispectral immunofluorescent staining for the juxtaposition of PCC cells (marked by CGA), CD4+ T cells (marked by CD4), CD8+ T cells (marked by CD8), M1 macrophages (marked by CD68), and M2 macrophages (marked by CD163) in formalin-fixed paraffin-embedded PCC tissue sections matched to scRNA-seq specimens. The white, yellow, cyan, green, pink, and blue spots indicated cells with high expression of CGA, CD4, CD8, CD68, CD163, and DAPI proteins in PCC tissue sections, respectively. S, stroma; T, tumor. Scale bar, 100 μm.